Results 221 to 230 of about 30,099 (284)

A national cross-sectional analysis of surveillance drug resistance mutations among recently diagnosed antiretroviral naïve Brazilian people with HIV. [PDF]

Lancet Reg Health Am
Caldeira DB, Constant Vergara TR, Schechter M, Bicudo EL, Freitas Lopes CA, Brites C, Sprinz E, Fernandes JC, Silveira OS, Durães-Carvalho R, Galinskas J, Treitsman MS, Gomes de Sousa MD, de Figueiredo Fernandes M, Helfer MS, Grilo NA, Caseiro MM, Sanz Duro RL, Bassini AS, Hunter JR, Janini LM, Diaz RS.   +21 more
europepmc   +1 more source

Characterization of drug resistance mutations in people living with HIV with low-level viremia on antiretroviral therapy in Chongqing, China. [PDF]

Front Public Health
Zhang H, Zhang Z, Ye W, Pan W.
europepmc   +1 more source

Prevalence of acquired resistance to HIV integrase strand transfer inhibitors (INSTIs) in clinical samples from treatment-experienced patients in Chile, 2012-2023. [PDF]

J Virus Erad
Ferrer P, Ramos V, Durán M, Maureira D, Beltrán C, Afani A.   +5 more
europepmc   +1 more source

Cytopenias With HIV in the Era of Highly Active Antiretroviral Therapy: Are We Winning the Battle? [PDF]

Health Sci Rep
Obeagu EI.
europepmc   +1 more source

HIV drug resistance amongst children and adolescents with viraemia in Lesotho and Tanzania: a nested analysis in the GIVE MOVE trial. [PDF]

J Antimicrob Chemother
Schönenberger CM, Haenggi K, Ringera IK, Luoga E, Bresser M, Mothobi B, Mokhele K, Sando D, Molatelle M, Thahane L, Mnzava D, Ndege R, Hlasoa MM, Kayembe BP, Muhairwe J, Glass TR, Klimkait T, Weisser M, Labhardt ND, Tschumi N, Brown JA.   +20 more
europepmc   +1 more source

Prevalence of primary HIV-1 drug resistance among antiretroviral-naïve individuals in Togo in 2023: a national study. [PDF]

Front Public Health
Ouro-Medeli A, Togan RM, Serrano L, Butel C, Atoun R, Youa F, Ali-Edje K, Douffan M, Ehlan P, Tegueni K, Amenti R, Konou AA, Salou M, Ekouevi DK, Peeters M, Dagnra AC.   +15 more
europepmc   +1 more source